Company profile EQ

Equillium Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 22:08:59.

After 39 days of this quarter the interest is at 6.0. Based on that we can calculate that during remaining 52 days it will total up to 14.0.
Equillium expected interest is significantly higher compared to previous quarter (+75.0%) but similar to same quarter last year.

YearQ1Q2Q3Q4
20194
7
75.0% QoQ
12
71.4% QoQ
8
-33.3% QoQ
2020 12
200.0% YoY 50.0% QoQ
12
71.4% YoY 0.0% QoQ
148
1133.3% YoY 1133.3% QoQ
34
325.0% YoY -77.0% QoQ
2021 22
83.3% YoY -35.3% QoQ
19
58.3% YoY -13.6% QoQ
18
-87.8% YoY -5.3% QoQ
9
-73.5% YoY -50.0% QoQ
2022 22
0.0% YoY 144.4% QoQ
7
-63.2% YoY -68.2% QoQ
19
5.6% YoY 171.4% QoQ
21
133.3% YoY 10.5% QoQ
2023 20
-9.1% YoY -4.8% QoQ
15
114.3% YoY -25.0% QoQ
18
-5.3% YoY 20.0% QoQ
8
-61.9% YoY -55.6% QoQ
2024 6
-70.0% YoY -25.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Equillium search interestLast update: February 08 2024 22:08:59.
Correlation coefficient between keyword and revenue is 0.59
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:09:00.

The average 5 years interest of Equillium was 1.69 per week.
The last year interest of Equillium compared to the last 5 years has changed by -31.95%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 57.53%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Equillium itolizumab to provide analysis

Correlation between past revenue and Equillium itolizumab search interest

There is not enough data for Equillium itolizumab to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Equillium itolizumab to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Equillium clinical trials to provide analysis

Correlation between past revenue and Equillium clinical trials search interest

There is not enough data for Equillium clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Equillium clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Equillium autoimmune disorders to provide analysis

Correlation between past revenue and Equillium autoimmune disorders search interest

There is not enough data for Equillium autoimmune disorders to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Equillium autoimmune disorders to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Equillium inflammatory disorders to provide analysis

Correlation between past revenue and Equillium inflammatory disorders search interest

There is not enough data for Equillium inflammatory disorders to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Equillium inflammatory disorders to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Equillium cutaneous T cell lymphoma to provide analysis

Correlation between past revenue and Equillium cutaneous T cell lymphoma search interest

There is not enough data for Equillium cutaneous T cell lymphoma to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Equillium cutaneous T cell lymphoma to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Equillium gastrointestinal diseases to provide analysis

Correlation between past revenue and Equillium gastrointestinal diseases search interest

There is not enough data for Equillium gastrointestinal diseases to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Equillium gastrointestinal diseases to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Equillium jobs to provide analysis

Correlation between past revenue and Equillium jobs search interest

There is not enough data for Equillium jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Equillium jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 22:10:13.

After 39 days of this quarter the interest is at 112.0. Based on that we can calculate that during remaining 52 days it will total up to 261.0.
Equillium stock price expected interest is significantly higher compared to previous quarter (+262.5%) and same quarter last year (+inf%).

YearQ1Q2Q3Q4
201957
31
-45.6% QoQ
56
80.6% QoQ
49
-12.5% QoQ
2020 74
29.8% YoY 51.0% QoQ
20
-35.5% YoY -73.0% QoQ
96
71.4% YoY 380.0% QoQ
94
91.8% YoY -2.1% QoQ
2021 53
-28.4% YoY -43.6% QoQ
40
100.0% YoY -24.5% QoQ
49
-49.0% YoY 22.5% QoQ
51
-45.7% YoY 4.1% QoQ
2022 42
-20.8% YoY -17.6% QoQ
29
-27.5% YoY -31.0% QoQ
49
0.0% YoY 69.0% QoQ
56
9.8% YoY 14.3% QoQ
2023 0
-100.0% YoY -100.0% QoQ
52
79.3% YoY inf% QoQ
42
-14.3% YoY -19.2% QoQ
72
28.6% YoY 71.4% QoQ
2024 112
inf% YoY 55.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Equillium stock price search interestLast update: February 08 2024 22:09:05.
Correlation coefficient between keyword and revenue is 0.16
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:10:13.

The average 5 years interest of Equillium stock price was 4.31 per week.
The last year interest of Equillium stock price compared to the last 5 years has changed by 24.13%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 24.13%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 22:10:17.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Equillium news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
20198
21
162.5% QoQ
66
214.3% QoQ
26
-60.6% QoQ
2020 41
412.5% YoY 57.7% QoQ
22
4.8% YoY -46.3% QoQ
180
172.7% YoY 718.2% QoQ
33
26.9% YoY -81.7% QoQ
2021 58
41.5% YoY 75.8% QoQ
44
100.0% YoY -24.1% QoQ
69
-61.7% YoY 56.8% QoQ
32
-3.0% YoY -53.6% QoQ
2022 66
13.8% YoY 106.2% QoQ
8
-81.8% YoY -87.9% QoQ
35
-49.3% YoY 337.5% QoQ
36
12.5% YoY 2.9% QoQ
2023 6
-90.9% YoY -83.3% QoQ
34
325.0% YoY 466.7% QoQ
59
68.6% YoY 73.5% QoQ
93
158.3% YoY 57.6% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Equillium news search interestLast update: February 08 2024 22:09:13.
Correlation coefficient between keyword and revenue is 0.31
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:10:17.

The average 5 years interest of Equillium news was 3.59 per week.
The last year interest of Equillium news compared to the last 5 years has changed by -0.28%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 53.65%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for EQ
Earnings date: 2024-03-21 After close
Company name: Equillium Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-13T20:01:00Z

GlobeNewswire
Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights

2026-05-01T20:42:32Z

GlobeNewswire
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-04-20T20:05:00Z

GlobeNewswire
Equillium to Participate in Oppenheimer's 2026 Innovation on the Island Event

2026-04-17T17:47:35Z

Analyst Upgrades
Roth Capital Reiterates Buy on Equillium, Maintains $12 Price Target

2026-04-16T18:04:31Z

Analyst Upgrades
B. Riley Securities Initiates Coverage On Equillium with Buy Rating, Announces Price Target of $6

2026-04-14T11:36:19Z

Analyst Upgrades
Raymond James Initiates Coverage On Equillium with Strong Buy Rating, Announces Price Target of $6

2026-04-08T12:30:00Z

GlobeNewswire
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists

2026-04-07T12:25:17Z

Analyst Upgrades
Cantor Fitzgerald Initiates Coverage On Equillium with Overweight Rating, Announces Price Target of $10

2026-04-02T20:05:00Z

GlobeNewswire
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-03-25T20:05:00Z

GlobeNewswire
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights

2026-03-13T17:50:38Z

Analyst Upgrades
Roth Capital Initiates Coverage On Equillium with Buy Rating, Announces Price Target of $12

2026-03-13T12:00:00Z

GlobeNewswire
Equillium Announces $35 Million Financing with RA Capital Management

2026-02-25T13:30:00Z

GlobeNewswire
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference

2026-02-02T21:05:00Z

GlobeNewswire
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2025-11-20T21:35:12Z

GlobeNewswire
Equillium to Participate in Upcoming Investor Conferences